[SARS].
Kawana
Akihiko
A
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control; D004196:Disease Outbreaks; D004203:Disinfection; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010356:Patient Isolation; D011379:Prognosis; D011481:Protective Clothing; D045473:Severe acute respiratory syndrome-related coronavirus / Q000472:pathogenicity*; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D014218:Triage; D014691:Ventilation / Q000379:methods; D014944:World Health Organization; D015047:Zoonoses
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D007155:Immunologic Factors